Document is current
Any future updates will be listed below
-
Authors
Edler, Peta
Schwab, Lara S. U.
Aban, Malet
Wille, Michelle https://orcid.org/0000-0002-5629-0196
Spirason, Natalie
Deng, Yi-Mo
Carlock, Michael A.
Ross, Ted M. https://orcid.org/0000-0003-1947-7469
Juno, Jennifer A. https://orcid.org/0000-0002-9072-1017
Rockman, Steve
Wheatley, Adam K. https://orcid.org/0000-0002-5593-9387
Kent, Stephen J. https://orcid.org/0000-0002-8539-4891
Barr, Ian G. https://orcid.org/0000-0002-7351-418X
Price, David J. https://orcid.org/0000-0003-0076-3123
Koutsakos, Marios https://orcid.org/0000-0001-9994-9723
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council
Morningside Foundation
- License Information
-
More Information
Article History
Received: 28 August 2023
Accepted: 15 May 2024
First Online: 18 June 2024
Competing interests
: M.K. has acted as a consultant for Sanofi group of companies. S.R. is an employee of Seqirus, an influenza vaccine manufacturer. I.G.B. has shares in an influenza-vaccine-producing company. The other authors declare no competing interests.
